Industries | Biotech | EP&C Patent Attorneys

Biotech success starts with strategic IP, not just science

The path to market in biotechnology is long, complex, and capital-intensive. At EP&C, we understand that patents are business-critical assets that drive innovation and influence how companies raise capital. We integrate IP strategy tightly with your R&D and funding milestones, maximising your chances of survival, growth, and successful exit.

We serve scientific pioneers, founders, and business leaders across Red (healthcare/medicine), Green (agriculture/plant sciences), and White (industrial) biotech sectors. We focus on the life sciences and biotech, acknowledging that most of our clients have a health purpose. Our commitment is to clarity, ensuring we deliver actionable recommendations, not just confusing analyses, so you fully understand every decision you make.

More case studies

We solve your biggest biotech challenges

You face unique hurdles in this highly regulated and uncertain industry. We address critical challenges by ensuring your IP strategy aligns perfectly with your business goals:

Navigating uncertainty

Experiments spanning years often don't yield definitive results, yet delaying patent filing is risky. We help you file based on plausibility to secure priority dates early.

Securing critical funding

For early-stage companies, IP is often the sole asset. You need a robust patent portfolio to attract investment and obtain the funds necessary for continued development.

Balancing science and investor expectations

We strategically shape your applications to satisfy investors, who can be deterred by a negative opinion in an initial search report.

Complex regulatory alignment

Integrating IP with strict regulatory requirements, such as food safety or GMO regulations, is crucial for market entry and scale.

Global enforcement

Protecting key assets, like microbial strains for therapeutic use, against unauthorised online sales requires a multifaceted strategy.

See our capabilities

Protecting your market exclusivity

Download our strategic enforcement guide

Learn how to combine the Patent Route with Regulatory and Digital Measures to protect your microbial strains, therapies, and innovations against global infringers.

Download now

You gain PhD-backed insight

You work directly with attorneys, all generally holding PhDs in life sciences, who fully understand your complex experiments and scientific rationale.

We integrate early for IP harvesting

We work closely with your team, often joining R&D and board meetings for crucial "IP harvesting," identifying and shaping inventions while they are still in development.

We secure momentum with plausible filings

This early integration allows us to base your filings on the scientific plausibility of your results, leveraging rationale and predictive examples to file earlier and secure priority dates, even before definitive proof is achieved.

We transform your IP portfolio into a strategic business asset

We bolster investor confidence

We design your IP strategy to clear critical funding milestones. When investment is the immediate priority, we may advise strategically narrowing claims to secure a positive search report, which is a tactical move to maintain investor confidence.

We tailor protection to your goals

Whether you pursue an offensive strategy to establish market exclusivity, requiring a watertight "fortress of plausibility," or a defensive strategy focused on freedom to operate, we tailor the application writing to your specific business model.

We offer powerful regulatory alignment

We strategically align your IP with regulatory approval (e.g., EU Regulation). A narrow patent aligned precisely with a regulatory-approved process offers immense protection, as bypassing the patent often means stepping outside regulatory boundaries.

We provide global reach

Our global network of agents and strong expertise in the US IP system ensure you receive comprehensive protection in critical international markets, especially given the US market’s importance for investors.

Trusted voices in biotech IP

View our success stories

"Working with EP&C is productive, pleasant, and constructive. They are fast, professional, and deeply understand the essence of our innovations."

Michiel van Eijk

CEO, Genetwister

SUCCESS STORY

Read the Genetwister story

Discover how EP&C helped Genetwister, the Wageningen-based biotech powerhouse, protect its proprietary technology and drive genetic advancement for a better global food future.

Download now

More case studies